Use of Patient Derived Tumoroids to Model Triple Negative Breast Cancer

This poster was presented at MDIBL2021 Symposium: Applications of Organoid Technlogy. In collaboration with Matt Burow’s group at Tulane University and Oksana Sirenko and her team at Molecular Devices, Inc, we have demonstrated the use of the Pu·MA System 3D for assays to efficiently perform:

• automated drug treatment of patient-derived tumoroids to study drug response
• immunofluorescence staining of tumoroids
• high content imaging of tumoroids within the flowchips after the assay